Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Fonatsch, C; Nowotny, H; Pittermann-Hocker, E; Streubel, B; Jager, U; Valent, P; Buchner, T; Lechner, K
   Amplification of ribosomal RNA genes in acute myeloid leukemia
   GENES CHROMOSOMES & CANCER
   
   C. Fonatsch et al., "Amplification of ribosomal RNA genes in acute myeloid leukemia", GENE CHROM, 32(1), 2001, pp. 11-17
2. Exner, M; Thalhammer-Scherrer, R; Kudlacek, S; Simonitsch, I; Jager, U; Schwarzinger, I
   Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells
   LEUKEMIA & LYMPHOMA
   
   M. Exner et al., "Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells", LEUK LYMPH, 42(1-2), 2001, pp. 239-241
3. Keil, F; Prinz, F; Kalhs, P; Lechner, K; Moser, K; Schwarzinger, I; Jager, U; Fonatsch, C; Worel, N; Mannhalter, C; Rabitsch, W; Loidolt, H; Schulenburg, A; Mitterbauer, M; Hocker, P; Greinix, HT
   Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants
   LEUKEMIA
   
   F. Keil et al., "Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants", LEUKEMIA, 15(3), 2001, pp. 355-361
4. Selenko, N; Majdic, O; Draxler, S; Berer, A; Jager, U; Knapp, W; Stockl, J
   CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8(+) cytotoxic T cells
   LEUKEMIA
   
   N. Selenko et al., "CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8(+) cytotoxic T cells", LEUKEMIA, 15(10), 2001, pp. 1619-1626
5. Falkenbach, A; Jager, U
   Is chronic lymphocytic leukemia a contraindication for radon and thermotherapy? - A case report
   WIENER KLINISCHE WOCHENSCHRIFT
   
   A. Falkenbach e U. Jager, "Is chronic lymphocytic leukemia a contraindication for radon and thermotherapy? - A case report", WIEN KLIN W, 113(1-2), 2001, pp. 73-75
6. Pirc-Danoewinata, H; Dauwerse, HG; Konig, M; Chudoba, I; Mitterbauer, M; Jager, U; Breuning, MH; Haas, OA
   CBFB/MYHII fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16
   GENES CHROMOSOMES & CANCER
   
   H. Pirc-Danoewinata et al., "CBFB/MYHII fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16", GENE CHROM, 29(2), 2000, pp. 186-191
7. Streubel, B; Valent, P; Jager, U; Edelhauser, M; Wandt, H; Wagner, T; Buchner, T; Lechner, K; Fonatsch, C
   Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome
   GENES CHROMOSOMES & CANCER
   
   B. Streubel et al., "Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome", GENE CHROM, 27(4), 2000, pp. 380-386
8. Mavria, G; Jager, U; Porter, CD
   Generation of a high titre retroviral vector for endothelial cell-specificgene expression in vivo
   GENE THERAPY
   
   G. Mavria et al., "Generation of a high titre retroviral vector for endothelial cell-specificgene expression in vivo", GENE THER, 7(5), 2000, pp. 368-376
9. Greinix, HT; Loidolt, H; Rabitsch, W; Schulenburg, A; Keil, F; Mitterbauer, M; Laczika, K; Lechner, K; Dieckmann, K; Fischer, G; Jager, U; Rosenmayr, A; Knobl, P; Schwarzinger, I; Hocker, P; Mannhalter, C; Hinterberger, W; Haas, OA; Fonatsch, C; Kalhs, P
   Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia
   ANNALS OF HEMATOLOGY
   
   H.T. Greinix et al., "Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia", ANN HEMATOL, 79(4), 2000, pp. 206-213
10. Thalhammer-Scherrer, R; Geissler, K; Schwarzinger, I; Chott, A; Gisslinger, H; Knobl, P; Lechner, K; Jager, U
    Fludarabine therapy in Waldenstrom's macroglobulinemia
    ANNALS OF HEMATOLOGY
    
    R. Thalhammer-Scherrer et al., "Fludarabine therapy in Waldenstrom's macroglobulinemia", ANN HEMATOL, 79(10), 2000, pp. 556-559
11. Konigsberg, R; Ackermann, J; Kaufmann, H; Zojer, N; Urbauer, E; Kromer, E; Jager, U; Gisslinger, H; Schreiber, S; Heinz, R; Ludwig, H; Huber, H; Drach, J
    Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance
    LEUKEMIA
    
    R. Konigsberg et al., "Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance", LEUKEMIA, 14(11), 2000, pp. 1975-1979
12. Filipits, M; Stranzl, T; Pohl, G; Heinzl, H; Jager, U; Geissler, K; Fonatsch, C; Haas, OA; Lechner, K; Pirker, R
    Drug resistance factors in acute myeloid leukemia: a comparative analysis
    LEUKEMIA
    
    M. Filipits et al., "Drug resistance factors in acute myeloid leukemia: a comparative analysis", LEUKEMIA, 14(1), 2000, pp. 68-76
13. Konigsberg, R; Zojer, N; Ackermann, J; Kromer, E; Kittler, H; Fritz, E; Kaufmann, H; Nosslinger, T; Riedl, L; Gisslinger, H; Jager, U; Simonitsch, I; Heinz, R; Ludwig, H; Huber, H; Drach, J
    Predictive role of interphase cytogenetics for survival of patients with multiple myeloma
    JOURNAL OF CLINICAL ONCOLOGY
    
    R. Konigsberg et al., "Predictive role of interphase cytogenetics for survival of patients with multiple myeloma", J CL ONCOL, 18(4), 2000, pp. 804-812
14. Exner, M; Thalhammer, R; Kapiotis, S; Mitterbauer, G; Knobl, P; Haas, OA; Jager, U; Schwarzinger, I
    The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?
    CYTOMETRY
    
    M. Exner et al., "The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?", CYTOMETRY, 42(2), 2000, pp. 106-109
15. Fureder, W; Streubel, B; Jordan, JH; Walchshofer, S; Wimazal, F; Jager, U; Geissler, K; Schwartz, LB; Chott, A; Lechner, K; Valent, P; Fonatsch, C
    Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvementin an unusual myelogenous disorder with bath myeloproliferative and dysplastic features
    CANCER GENETICS AND CYTOGENETICS
    
    W. Fureder et al., "Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvementin an unusual myelogenous disorder with bath myeloproliferative and dysplastic features", CANC GENET, 121(2), 2000, pp. 133-138
16. Geissler, K; Gisslinger, H; Knobl, P; Sperr, W; Valent, P; Dieckmann, K; Chott, A; Potter, R; Lechner, K; Jager, U
    Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience
    WIENER KLINISCHE WOCHENSCHRIFT
    
    K. Geissler et al., "Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience", WIEN KLIN W, 112(14), 2000, pp. 624-628
17. Wieser, R; Volz, A; Schnittger, S; Jager, U; Gruner, H; Meran, JG; Wimmer, K; Ziegler, A; Fonatsch, C
    Mapping of leukaemia-associated breakpoints in chromosome band 3q21 using a newly established PAC contig
    BRITISH JOURNAL OF HAEMATOLOGY
    
    R. Wieser et al., "Mapping of leukaemia-associated breakpoints in chromosome band 3q21 using a newly established PAC contig", BR J HAEM, 110(2), 2000, pp. 343-350
18. Mitterbauer, G; Zimmer, C; Pirc-Danoewinata, H; Haas, OA; Hojas, S; Schwarzinger, I; Greinix, H; Jager, U; Lechner, K; Mannhalter, C
    Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction
    BRITISH JOURNAL OF HAEMATOLOGY
    
    G. Mitterbauer et al., "Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction", BR J HAEM, 109(3), 2000, pp. 622-628
19. Jager, U; Bocskor, S; Le, T; Mitterbauer, G; Bolz, I; Chott, A; Kneba, M; Mannhalter, C; Nadel, B
    Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation
    BLOOD
    
    U. Jager et al., "Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation", BLOOD, 95(11), 2000, pp. 3520-3529
20. Wieser, R; Volz, A; Vinatzer, U; Gardiner, K; Jager, U; Mitterbauer, M; Ziegler, A; Fonatsch, C
    Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    R. Wieser et al., "Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia", BIOC BIOP R, 273(1), 2000, pp. 239-245
21. Fiegl, M; Mitterbauer, G; Weltermann, A; Pirc-Danoewinata, H; Jager, U
    Chronic myelogenous leukemia in chronic phase for 16 years: Ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy
    LEUKEMIA & LYMPHOMA
    
    M. Fiegl et al., "Chronic myelogenous leukemia in chronic phase for 16 years: Ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy", LEUK LYMPH, 35(3-4), 1999, pp. 409-413
22. Jager, U; Takeuchi, Y; Porter, CD
    Induction of complement attack on human cells by Gal(alpha 1,3)Gal xenoantigen expression as a gene therapy approach to cancer
    GENE THERAPY
    
    U. Jager et al., "Induction of complement attack on human cells by Gal(alpha 1,3)Gal xenoantigen expression as a gene therapy approach to cancer", GENE THER, 6(6), 1999, pp. 1073-1083
23. Meidlinger, P; Knobl, P; Jager, U; Gisslinger, H; Pabinger, I; Weltermann, A; Lechner, K; Geissler, K
    Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment
    ANNALS OF HEMATOLOGY
    
    P. Meidlinger et al., "Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment", ANN HEMATOL, 78(7), 1999, pp. 299-304
24. Lechner, K; Geissler, K; Jager, U; Greinix, H; Kalhs, P
    Treatment of acute leukemia
    ANNALS OF ONCOLOGY
    
    K. Lechner et al., "Treatment of acute leukemia", ANN ONCOL, 10, 1999, pp. 45-51
25. Fureder, W; Weltermann, A; Chott, A; Gisslinger, H; Valent, P; Jager, U; Geissler, K; Lechner, K
    Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine)
    WIENER KLINISCHE WOCHENSCHRIFT
    
    W. Fureder et al., "Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine)", WIEN KLIN W, 111(24), 1999, pp. 1027-1030
26. Jager, U; Zhao, Y; Porter, CD
    Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences
    JOURNAL OF VIROLOGY
    
    U. Jager et al., "Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences", J VIROLOGY, 73(12), 1999, pp. 9702-9709
27. Jager, U; Nguyen-Duong, H
    Relaxant effect of trans-resveratrol on isolated porcine coronary arteries
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    U. Jager e H. Nguyen-Duong, "Relaxant effect of trans-resveratrol on isolated porcine coronary arteries", ARZNEI-FOR, 49(3), 1999, pp. 207-211
28. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
    HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS
    Leukemia
    
    A. Weltermann et al., "HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS", Leukemia, 12(8), 1998, pp. 1182-1186
29. Gaiger, A; Schmid, D; Heinze, G; Linnerth, B; Greinix, H; Kalhs, P; Tisljar, K; Priglinger, S; Laczika, K; Mitterbauer, M; Novak, M; Mitterbauer, G; Mannhalter, C; Haas, OA; Lechner, K; Jager, U
    Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia
    LEUKEMIA
    
    A. Gaiger et al., "Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia", LEUKEMIA, 12(12), 1998, pp. 1886-1894
30. SCHETT G; CASATI B; WILLINGER B; WEINLANDRE G; BINDER T; GRABENWOGER F; SPERR W; GEISSLER K; JAGER U
    ENDOCARDITIS AND AORTIC EMBOLIZATION CAUSED BY ASPERGILLUS-TERREUS INA PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN REMISSION - DIAGNOSIS BY PERIPHERAL-BLOOD CULTURE
    Journal of clinical microbiology (Print)
    
    G. Schett et al., "ENDOCARDITIS AND AORTIC EMBOLIZATION CAUSED BY ASPERGILLUS-TERREUS INA PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN REMISSION - DIAGNOSIS BY PERIPHERAL-BLOOD CULTURE", Journal of clinical microbiology (Print), 36(11), 1998, pp. 3347-3351
31. LECHNER K; JAGER U; GEISSLER K; GREINIX H; KALHS P
    ADVANCES IN THE TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    Wiener Klinische Wochenschrift
    
    K. Lechner et al., "ADVANCES IN THE TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)", Wiener Klinische Wochenschrift, 110(20), 1998, pp. 701-708
32. MORRISON AM; JAGER U; CHOTT A; SCHEBESTA M; HAAS OA; BUSSLINGER M
    DEREGULATED PAX-5 TRANSCRIPTION FROM A TRANSLOCATED IGH PROMOTER IN MARGINAL ZONE LYMPHOMA
    Blood
    
    A.M. Morrison et al., "DEREGULATED PAX-5 TRANSCRIPTION FROM A TRANSLOCATED IGH PROMOTER IN MARGINAL ZONE LYMPHOMA", Blood, 92(10), 1998, pp. 3865-3878
33. FILIPITS M; POHL G; STRANZL T; SUCHOMEL RW; SCHEPER RJ; JAGER U; GEISSLER K; LECHNER K; PIRKER R
    EXPRESSION OF THE LUNG RESISTANCE PROTEIN PREDICTS POOR OUTCOME IN DE-NOVO ACUTE MYELOID-LEUKEMIA
    Blood
    
    M. Filipits et al., "EXPRESSION OF THE LUNG RESISTANCE PROTEIN PREDICTS POOR OUTCOME IN DE-NOVO ACUTE MYELOID-LEUKEMIA", Blood, 91(5), 1998, pp. 1508-1513
34. JAGER U; TAKEUCHI Y; PORTER CD
    SENSITIZATION OF HUMAN-CELLS TO LYSIS BY HUMAN-COMPLEMENT AS AN APPROACH FOR CANCER GENE-THERAPY
    Cancer gene therapy
    
    U. Jager et al., "SENSITIZATION OF HUMAN-CELLS TO LYSIS BY HUMAN-COMPLEMENT AS AN APPROACH FOR CANCER GENE-THERAPY", Cancer gene therapy, 4(5), 1997, pp. 301-301
35. SCHMID D; HEINZE G; LINNERTH B; TISLJAR K; KUSEC R; GEISSLER K; SILLABER C; LACZIKA K; MITTERBAUER M; ZOCHBAUER S; MANNHALTER C; HAAS OA; LECHNER K; JAGER U; GAIGER A
    PROGNOSTIC-SIGNIFICANCE OF WT1 GENE-EXPRESSION AT DIAGNOSIS IN ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA
    Leukemia
    
    D. Schmid et al., "PROGNOSTIC-SIGNIFICANCE OF WT1 GENE-EXPRESSION AT DIAGNOSIS IN ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA", Leukemia, 11(5), 1997, pp. 639-643
36. MITTERBAUER M; HILGENFELD E; WILFING A; JAGER U; KNAUF WU
    IS THERE A PLACE FOR 2-CDA IN THE TREATMENT OF B-CLL
    Leukemia
    
    M. Mitterbauer et al., "IS THERE A PLACE FOR 2-CDA IN THE TREATMENT OF B-CLL", Leukemia, 11, 1997, pp. 35-37
37. HAAS M; JAGER U; MAYER G
    INTERFERON ALFA-2C AND PROTEINURIA IN A PATIENT WITH FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS
    Lancet
    
    M. Haas et al., "INTERFERON ALFA-2C AND PROTEINURIA IN A PATIENT WITH FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS", Lancet, 349(9059), 1997, pp. 1147-1148
38. TAKEUCHI Y; LIONG SH; BIENIASZ PD; JAGER U; PORTER CD; FRIEDMANN T; MCCLURE MO; WEISS RA
    SENSITIZATION OF RHABDOVIRUSES, LENTIVIRUSES, AND SPUMAVIRUSES TO HUMAN SERUM BY GALACTOSYL(ALPHA-1-3)GALACTOSYLATION
    Journal of virology
    
    Y. Takeuchi et al., "SENSITIZATION OF RHABDOVIRUSES, LENTIVIRUSES, AND SPUMAVIRUSES TO HUMAN SERUM BY GALACTOSYL(ALPHA-1-3)GALACTOSYLATION", Journal of virology, 71(8), 1997, pp. 6174-6178
39. SPERR WR; PIRIBAUER M; AGIS H; MITTERBAUER M; GEISSLER K; HAAS O; FONATSCH C; JAGER U; SCHWARZINGER I; THALHAMMER F; VALENT P; LECHNER K
    INTERMITTENT INTERMEDIATE-DOSE ARA-C AS CONSOLIDATION THERAPY FOR AMLIN THE ELDERLY
    Blood
    
    W.R. Sperr et al., "INTERMITTENT INTERMEDIATE-DOSE ARA-C AS CONSOLIDATION THERAPY FOR AMLIN THE ELDERLY", Blood, 90(10), 1997, pp. 2267-2267
40. PIRKER R; POHL G; STRANZL T; SUCHOMEL RW; SCHEPER RJ; JAGER U; GEISSLER K; LECHNER K; FILIPITS M
    EXPRESSION OF THE LUNG RESISTANCE PROTEIN (LRP) PREDICTS POOR OUTCOMEIN DE-NOVO ACUTE MYELOID-LEUKEMIA
    Blood
    
    R. Pirker et al., "EXPRESSION OF THE LUNG RESISTANCE PROTEIN (LRP) PREDICTS POOR OUTCOMEIN DE-NOVO ACUTE MYELOID-LEUKEMIA", Blood, 90(10), 1997, pp. 2519-2519
41. HUHMANN IM; WATZKE HH; GEISSLER K; GISSLINGER H; JAGER U; KNOBL P; PABINGER I; KORNINGER L; MANNHALTER C; MITTERBAUER G; SCHWARZINGER I; KALHS P; HAAS OA; LECHNER K
    FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA
    Annals of hematology
    
    I.M. Huhmann et al., "FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA", Annals of hematology, 73(6), 1996, pp. 265-271
42. THALHAMMER F; GEISSLER K; JAGER U; KYRLE PA; PABINGER I; MITTERBAUER M; GISSLINGER H; KNOBL P; LACZIKA K; SCHNEIDER B; HAAS OA; LECHNER K
    DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY
    Annals of hematology
    
    F. Thalhammer et al., "DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY", Annals of hematology, 72(4), 1996, pp. 216-222
43. GREINIX HT; KEIL F; BRUGGER SA; REITER E; LINKESCH W; LECHNER K; SCHNEIDER B; DIECKMANN KU; FISCHER G; SCHWARZINGER I; HAAS O; HINTERBERGER W; MANNHALTER C; GEISSLER K; HOCKER P; JAGER U; KALHS P
    LONG-TERM LEUKEMIA-FREE SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
    Annals of hematology
    
    H.T. Greinix et al., "LONG-TERM LEUKEMIA-FREE SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA", Annals of hematology, 72(2), 1996, pp. 53-59
44. HAAS M; MANNHALTER C; ULLRICH R; SCHWARZINGER I; ZUCKERMANN A; DERFLER K; JAGER U
    A MULTILOCULAR B-CELL NEOPLASIA PRESENTING AS MULTIPLE-MYELOMA AND POLYMORPHIC LYMPHOMA OF RECIPIENT ORIGIN 2 MONTHS AFTER KIDNEY-TRANSPLANTATION IN A HEART-TRANSPLANT RECIPIENT
    Nephrology, dialysis, transplantation
    
    M. Haas et al., "A MULTILOCULAR B-CELL NEOPLASIA PRESENTING AS MULTIPLE-MYELOMA AND POLYMORPHIC LYMPHOMA OF RECIPIENT ORIGIN 2 MONTHS AFTER KIDNEY-TRANSPLANTATION IN A HEART-TRANSPLANT RECIPIENT", Nephrology, dialysis, transplantation, 11(10), 1996, pp. 2085-2087
45. FAGETH R; ALLEN WG; JAGER U
    FUZZY-LOGIC CLASSIFICATION IN IMAGE-PROCESSING
    Fuzzy sets and systems
    
    R. Fageth et al., "FUZZY-LOGIC CLASSIFICATION IN IMAGE-PROCESSING", Fuzzy sets and systems, 82(3), 1996, pp. 265-278
46. JAGER U; LACZIKA K; SCHOLTEN C; MITTERBAUER M; NOVAK M; LECHNER K
    CLINICAL USE OF THE POLYMERASE CHAIN-REAC TION FOR DIAGNOSIS AND MONITORING OF MALIGNANT DISEASES
    Wiener Klinische Wochenschrift
    
    U. Jager et al., "CLINICAL USE OF THE POLYMERASE CHAIN-REAC TION FOR DIAGNOSIS AND MONITORING OF MALIGNANT DISEASES", Wiener Klinische Wochenschrift, 108(20), 1996, pp. 634-639
47. LORKOVIC H; JAGER U
    CHLORPROMAZINE AND DILTIAZEM EFFECTS IN MUSCLE - BLOCKAGE OF ACETYLCHOLINE-EVOKED CONTRACTURES, MEMBRANE CURRENTS AND TRACER CALCIUM-UPTAKE
    Pharmacology
    
    H. Lorkovic e U. Jager, "CHLORPROMAZINE AND DILTIAZEM EFFECTS IN MUSCLE - BLOCKAGE OF ACETYLCHOLINE-EVOKED CONTRACTURES, MEMBRANE CURRENTS AND TRACER CALCIUM-UPTAKE", Pharmacology, 53(1), 1996, pp. 11-18
48. COLLINS M; TAKEUCHI Y; PORTER C; JAGER U; MARTIN P; EVERARD M; PALMER K; BRIDGEWATER J; BOX G; WEISS R
    RETROVIRUSES FOR GENE-THERAPY
    Immunology
    
    M. Collins et al., "RETROVIRUSES FOR GENE-THERAPY", Immunology, 89, 1996, pp. 4-4
49. FODINGER M; BUCHMAYER H; SCHWARZINGER I; SIMONITSCH I; WINKLER K; JAGER U; KNOBLER R; MANNHALTER C
    MULTIPLEX PCR FOR RAPID DETECTION OF T-CELL RECEPTOR-GAMMA CHAIN GENEREARRANGEMENTS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES
    British Journal of Haematology
    
    M. Fodinger et al., "MULTIPLEX PCR FOR RAPID DETECTION OF T-CELL RECEPTOR-GAMMA CHAIN GENEREARRANGEMENTS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES", British Journal of Haematology, 94(1), 1996, pp. 136-139
50. LORKOVIC H; JAGER U; RADOCAJ A
    COMPARISON OF THE EFFECTS OF CA2-PLATE CURRENTS IN MOUSE INTEROSSEUS MUSCLES( AND THOSE OF MG2+ AND LA3+ ON END)
    Comparative biochemistry and physiology. Part A, Physiology
    
    H. Lorkovic et al., "COMPARISON OF THE EFFECTS OF CA2-PLATE CURRENTS IN MOUSE INTEROSSEUS MUSCLES( AND THOSE OF MG2+ AND LA3+ ON END)", Comparative biochemistry and physiology. Part A, Physiology, 111(4), 1995, pp. 597-602
51. TRIBL B; KNOBL P; DERFLER K; KAPIOTIS S; ASPOCK G; JAGER U; HORL W; LECHNER K
    RAPID ELIMINATION OF A HIGH-TITER SPONTANEOUS FACTOR-V ANTIBODY BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION AND IMMUNOSUPPRESSION
    Annals of hematology
    
    B. Tribl et al., "RAPID ELIMINATION OF A HIGH-TITER SPONTANEOUS FACTOR-V ANTIBODY BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION AND IMMUNOSUPPRESSION", Annals of hematology, 71(4), 1995, pp. 199-203
52. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIERDOBERSBERGER T; HORL W; LECHNER K; PABINGER I
    ELIMINATION OF ACQUIRED FACTOR-VIII ANTIBODIES BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION (IG-THERASORB(R))
    Thrombosis and haemostasis
    
    P. Knobl et al., "ELIMINATION OF ACQUIRED FACTOR-VIII ANTIBODIES BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION (IG-THERASORB(R))", Thrombosis and haemostasis, 74(4), 1995, pp. 1035-1038
53. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIENDOBERSBERGER T; TRIBL B; SPEISER W; DRUML W; PABINGER I; LECHNER K
    ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS
    Thrombosis and haemostasis
    
    P. Knobl et al., "ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS", Thrombosis and haemostasis, 73(6), 1995, pp. 1423-1423
54. DRACH J; SCHUSTER J; NOWOTNY H; ANGERLER J; ROSENTHAL F; FIEGL M; ROTHERMUNDT C; GSUR A; JAGER U; HEINZ R; LECHNER K; LUDWIG H; HUBER H
    MULTIPLE-MYELOMA - HIGH-INCIDENCE OF CHROMOSOMAL ANEUPLOIDY AS DETECTED BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION
    Cancer research
    
    J. Drach et al., "MULTIPLE-MYELOMA - HIGH-INCIDENCE OF CHROMOSOMAL ANEUPLOIDY AS DETECTED BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION", Cancer research, 55(17), 1995, pp. 3854-3859
55. MITTERBAUER G; FODINGER M; SCHERRER R; KNOBL P; JAGER U; LACZIKA K; SCHWARZINGER I; GAIGER A; GEISSLER K; GREINIX H; KALHS P; LINKESCH W; LECHNER K; MANNHALTER C
    PCR-MONITORING OF MINIMAL RESIDUAL LEUKEMIA AFTER CONVENTIONAL CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    British Journal of Haematology
    
    G. Mitterbauer et al., "PCR-MONITORING OF MINIMAL RESIDUAL LEUKEMIA AFTER CONVENTIONAL CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA", British Journal of Haematology, 89(4), 1995, pp. 937-941
56. REITER E; OHLER L; MAJDIC O; JAGER U; LECHNER K; GEISSLER K
    DOWN-REGULATION OF UROKINASE RECEPTOR (CD87) EXPRESSION BY IL-4 ON U937 MONONUCLEAR PHAGOCYTES
    Blood
    
    E. Reiter et al., "DOWN-REGULATION OF UROKINASE RECEPTOR (CD87) EXPRESSION BY IL-4 ON U937 MONONUCLEAR PHAGOCYTES", Blood, 86(10), 1995, pp. 2027-2027
57. REITER E; OHLER L; MAJDIC O; JAGER U; LECHNER K; GEISSLER K
    DOWN-REGULATION OF UROKINASE RECEPTOR (CD87) EXPRESSION BY IL-4 ON U937 MONONUCLEAR PHAGOCYTES
    Blood
    
    E. Reiter et al., "DOWN-REGULATION OF UROKINASE RECEPTOR (CD87) EXPRESSION BY IL-4 ON U937 MONONUCLEAR PHAGOCYTES", Blood, 86(10), 1995, pp. 2030-2030
58. GEISSLER K; OHLER L; REITER E; KABRNA E; ROGY M; FODINGER M; MANNHALTER C; JAGER U; LECHNER K
    INHIBITORY EFFECT OF INTERLEUKIN-10 ON THE AUTONOMOUS IN-VITRO GROWTHOF CHRONIC MYELOMONOCYTIC LEUKEMIA-CELLS
    Blood
    
    K. Geissler et al., "INHIBITORY EFFECT OF INTERLEUKIN-10 ON THE AUTONOMOUS IN-VITRO GROWTHOF CHRONIC MYELOMONOCYTIC LEUKEMIA-CELLS", Blood, 86(10), 1995, pp. 2645-2645
59. DRACH J; ANGERLER J; SCHUSTER J; ROTHERMUNDT C; THALHAMMER R; HAAS OA; JAGER U; FIEGL M; GEISSLER K; LUDWIG H; HUBER H
    INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IDENTIFIES CHROMOSOMAL-ABNORMALITIES IN PLASMA-CELLS FROM PATIENTS WITH MONOCLONAL GAMMOPATHYOF UNDETERMINED SIGNIFICANCE
    Blood
    
    J. Drach et al., "INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IDENTIFIES CHROMOSOMAL-ABNORMALITIES IN PLASMA-CELLS FROM PATIENTS WITH MONOCLONAL GAMMOPATHYOF UNDETERMINED SIGNIFICANCE", Blood, 86(10), 1995, pp. 3915-3921
60. LORKOVIC H; BALEZINA OP; JAGER U
    ACETYLCHOLINE-EVOKED CURRENTS IN JUVENILE MOUSE MUSCLES
    Comparative biochemistry and physiology. Part C, Pharmacology toxicology & endocrinology
    
    H. Lorkovic et al., "ACETYLCHOLINE-EVOKED CURRENTS IN JUVENILE MOUSE MUSCLES", Comparative biochemistry and physiology. Part C, Pharmacology toxicology & endocrinology, 107(3), 1994, pp. 373-377
61. GOTSCH U; JAGER U; DOMINIS M; VESTWEBER D
    EXPRESSION OF P-SELECTIN ON ENDOTHELIAL-CELLS IS UP-REGULATED BY LPS AND TNF-ALPHA IN-VIVO
    Cell adhesion and communication
    
    U. Gotsch et al., "EXPRESSION OF P-SELECTIN ON ENDOTHELIAL-CELLS IS UP-REGULATED BY LPS AND TNF-ALPHA IN-VIVO", Cell adhesion and communication, 2(1), 1994, pp. 7-14
62. SCHERRER R; BETTELHEIM P; GEISSLER K; JAGER U; KNOBL P; KYRLE PA; LACZIKA K; MITTERBAUER G; NEUMANN E; SCHNEIDER B; SCHWARZINGER I; LECHNER K
    HIGH EFFICACY OF THE GERMAN MULTICENTER ALL (GMALL) PROTOCOL FOR TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A SINGLE-INSTITUTION STUDY
    Annals of hematology
    
    R. Scherrer et al., "HIGH EFFICACY OF THE GERMAN MULTICENTER ALL (GMALL) PROTOCOL FOR TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A SINGLE-INSTITUTION STUDY", Annals of hematology, 69(4), 1994, pp. 181-188
63. THALHAMMER F; GISSLINGER H; CHOTT A; HAAS O; ETELEHAINZ A; HELBICH T; KUSEC R; LINKESCH W; SIMONITSCH I; STROBL H; LECHNER K; JAGER U
    GRANULOCYTIC SARCOMA OF THE PROSTATE AS THE 1ST MANIFESTATION OF A LATE RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA
    Annals of hematology
    
    F. Thalhammer et al., "GRANULOCYTIC SARCOMA OF THE PROSTATE AS THE 1ST MANIFESTATION OF A LATE RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA", Annals of hematology, 68(2), 1994, pp. 97-99
64. PIRCDANOEWINATA H; CHOTT A; ONDERKA E; DRACH J; SCHLOGL E; JAGER U; THALHAMMER F; NOWOTNY H; ARYEE D; STEGER GG; LOCKER G; MICHL I; DJAVANMARD M; SIMONITSCH I; RADASZKIEWICZ T; HANAK H; SCHNEIDER B; HEINZ R; MAROSI C
    KARYOTYPE AND PROGNOSIS IN NON-HODGKIN-LYMPHOMA
    Leukemia
    
    H. Pircdanoewinata et al., "KARYOTYPE AND PROGNOSIS IN NON-HODGKIN-LYMPHOMA", Leukemia, 8(11), 1994, pp. 1929-1939
65. NOLTE D; SCHMID P; JAGER U; BOTZLAR A; ROESKEN F; HECHT R; UHL E; MESSMER K; VESTWEBER D
    LEUKOCYTE ROLLING IN VENULES OF STRIATED-MUSCLE AND SKIN IS MEDIATED BY P-SELECTIN, NOT BY L-SELECTIN
    American journal of physiology. Heart and circulatory physiology
    
    D. Nolte et al., "LEUKOCYTE ROLLING IN VENULES OF STRIATED-MUSCLE AND SKIN IS MEDIATED BY P-SELECTIN, NOT BY L-SELECTIN", American journal of physiology. Heart and circulatory physiology, 36(4), 1994, pp. 80001637-80001642
66. BOCHER WO; LOHR HF; STEEGMULLER KW; STORKEL S; JAGER U; ZUMBUSCHENFELDE KHM; GERKEN G
    DETECTION OF HEPATITIS-C VIRUS-REPLICATION IN OVARIAN METASTASES OF APATIENT WITH HEPATOCELLULAR-CARCINOMA
    Journal of hepatology
    
    W.O. Bocher et al., "DETECTION OF HEPATITIS-C VIRUS-REPLICATION IN OVARIAN METASTASES OF APATIENT WITH HEPATOCELLULAR-CARCINOMA", Journal of hepatology, 21(1), 1994, pp. 47-51
67. JAGER U; DELLEKARTH G; KNAPP S; TUENI C
    TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMP HOMAS
    Wiener Klinische Wochenschrift
    
    U. Jager et al., "TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMP HOMAS", Wiener Klinische Wochenschrift, 106(10), 1994, pp. 315-320
68. HAHNE M; LENTER M; JAGER U; VESTWEBER D
    A NOVEL SOLUBLE FORM OF MOUSE VCAM-1 IS GENERATED FROM A GLYCOLIPID-ANCHORED SPLICING VARIANT
    European Journal of Immunology
    
    M. Hahne et al., "A NOVEL SOLUBLE FORM OF MOUSE VCAM-1 IS GENERATED FROM A GLYCOLIPID-ANCHORED SPLICING VARIANT", European Journal of Immunology, 24(2), 1994, pp. 421-428
69. REITER E; OHLER L; AGIS H; VALENT P; JAGER U; LECHNER K; GEISSLER K
    DIFFERENTIAL-EFFECTS OF IL-4 AND IL-10 ON THE EXPRESSION OF THE C3BI RECEPTOR ON HUMAN MONOCYTES MACROPHAGES
    Blood
    
    E. Reiter et al., "DIFFERENTIAL-EFFECTS OF IL-4 AND IL-10 ON THE EXPRESSION OF THE C3BI RECEPTOR ON HUMAN MONOCYTES MACROPHAGES", Blood, 84(10), 1994, pp. 10000031-10000031
70. DRACH J; ANGERLER J; SCHUSTER J; NOWOTNY H; SCHERRER R; JAGER U; HEINZ R; GEISSLER K; LECHNER K; LUDWIG H; HUBER H
    INTERPHASE CYTOGENETIC STUDIES IN MULTIPLE-MYELOMA (MM) AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
    Blood
    
    J. Drach et al., "INTERPHASE CYTOGENETIC STUDIES IN MULTIPLE-MYELOMA (MM) AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)", Blood, 84(10), 1994, pp. 10000173-10000173
71. LORBER C; WILLFORT A; OHLER L; JAGER U; SCHWARZINGER I; LECHNER K; GEISSLER K
    GRANULOCYTE-COLONY-STIMULATING FACTOR (RH G-CSF) AS AN ADJUNCT TO INTERFERON-ALPHA THERAPY OF NEUTROPENIC PATIENTS WITH HAIRY-CELL LEUKEMIA
    Annals of hematology
    
    C. Lorber et al., "GRANULOCYTE-COLONY-STIMULATING FACTOR (RH G-CSF) AS AN ADJUNCT TO INTERFERON-ALPHA THERAPY OF NEUTROPENIC PATIENTS WITH HAIRY-CELL LEUKEMIA", Annals of hematology, 67(1), 1993, pp. 13-16
72. SCHERRER R; GEISSLER K; KYRLE PA; GISSLINGER H; JAGER U; BETTELHEIM P; LACZIKA K; LOCKER G; SCHOLTEN C; SILLABER C; SCHWARZINGER I; THALHAMMER F; LECHNER K
    GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    Annals of hematology
    
    R. Scherrer et al., "GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)", Annals of hematology, 66(6), 1993, pp. 283-289
73. WILLFORT A; LORBER C; KAPIOTIS S; SERTL S; HAINZ R; KIRCHWEGER P; JAGER U; KYRLE PA; LECHNER K; GEISSLER K
    TREATMENT OF DRUG-INDUCED AGRANULOCYTOSIS WITH RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RH G-CSF)
    Annals of hematology
    
    A. Willfort et al., "TREATMENT OF DRUG-INDUCED AGRANULOCYTOSIS WITH RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RH G-CSF)", Annals of hematology, 66(5), 1993, pp. 241-244
74. GAIGER A; LION T; KALHS P; MITTERBAUER G; HENN T; HAAS O; FODINGER M; KIER P; FORSTINGER C; QUEHENBERGER P; HINTERBERGER W; JAGER U; LINKESCH W; MANNHALTER C; LECHNER K
    FREQUENT DETECTION OF BCR-ABL SPECIFIC MESSENGER-RNA IN PATIENTS WITHCHRONIC MYELOID-LEUKEMIA (CML) FOLLOWING ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    Leukemia
    
    A. Gaiger et al., "FREQUENT DETECTION OF BCR-ABL SPECIFIC MESSENGER-RNA IN PATIENTS WITHCHRONIC MYELOID-LEUKEMIA (CML) FOLLOWING ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION (BMT)", Leukemia, 7(11), 1993, pp. 1766-1772
75. KNOBL P; KAPIOTIS S; LACZIKA K; JAGER U; KYRLE A; SPEISER W; LECHNER K
    ATTENUATION OF THE HEMOSTATIC DISORDER IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID
    Thrombosis and haemostasis
    
    P. Knobl et al., "ATTENUATION OF THE HEMOSTATIC DISORDER IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID", Thrombosis and haemostasis, 69(6), 1993, pp. 878-878
76. HAHNE M; LENTER M; JAGER U; ISENMANN S; VESTWEBER D
    VCAM-1 IS NOT INVOLVED IN LPAM-1 (ALPHA(4)BETA(P) ALPHA(4)BETA(7)) MEDIATED BINDING OF LYMPHOMA-CELLS TO HIGH ENDOTHELIAL VENULES OF MUCOSA-ASSOCIATED LYMPH-NODES/
    European journal of cell biology
    
    M. Hahne et al., "VCAM-1 IS NOT INVOLVED IN LPAM-1 (ALPHA(4)BETA(P) ALPHA(4)BETA(7)) MEDIATED BINDING OF LYMPHOMA-CELLS TO HIGH ENDOTHELIAL VENULES OF MUCOSA-ASSOCIATED LYMPH-NODES/", European journal of cell biology, 61(2), 1993, pp. 290-298
77. OHLER L; SCHOLTEN C; REITER E; TIEFENGRABER E; JAGER U; STROBL H; LECHNER K; HOCKER P; GEISSLER K
    MOBILIZATION OF CIRCULATING HEMATOPOIETIC STEM-CELLS WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER CHEMOTHERAPY IN PATIENTS WITH MULTIPLE-MYELOMA
    Wiener Klinische Wochenschrift
    
    L. Ohler et al., "MOBILIZATION OF CIRCULATING HEMATOPOIETIC STEM-CELLS WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER CHEMOTHERAPY IN PATIENTS WITH MULTIPLE-MYELOMA", Wiener Klinische Wochenschrift, 105(20), 1993, pp. 580-584
78. HAHNE M; JAGER U; ISENMANN S; HALLMANN R; VESTWEBER D
    5 TUMOR NECROSIS FACTOR-INDUCIBLE CELL-ADHESION MECHANISMS ON THE SURFACE OF MOUSE ENDOTHELIOMA CELLS MEDIATE THE BINDING OF LEUKOCYTES
    The Journal of cell biology
    
    M. Hahne et al., "5 TUMOR NECROSIS FACTOR-INDUCIBLE CELL-ADHESION MECHANISMS ON THE SURFACE OF MOUSE ENDOTHELIOMA CELLS MEDIATE THE BINDING OF LEUKOCYTES", The Journal of cell biology, 121(3), 1993, pp. 655-664